Psychosis isn't just a symptom—it’s a serious mental health condition impacting millions globally. Conditions like schizophrenia, bipolar disorder, and severe depression are at the heart of this growing health crisis, disrupting normal brain function and deeply affecting daily life.

🔍 But what’s behind the rising numbers?
From genetic predispositions to sleep disorders, postpartum complications, substance abuse, and even neurodegenerative diseases—a wide range of risk factors is contributing to the psychosis epidemic.

💊 The medical world is responding fast!
Treatments like typical antipsychotics (haloperidol, chlorpromazine) are helping reduce symptoms like hallucinations and delusions by targeting the brain’s dopamine system. At the same time, cognitive behavioral therapy (CBT) is gaining traction as a powerful tool to help patients manage stress, improve problem-solving, and reclaim control over their mental health.

✨ Whether you're interested in mental health trends, medical breakthroughs, or how therapy is changing lives, this video breaks down everything you need to know about the psychosis treatment landscape.

👉 Don’t forget to like, comment, and subscribe for more insights into the world of mental health and neuroscience!

Report Link: https://www.imarcgroup.com/psychosis-market

Contact us:

IMARC Group
134 N 4th St., Brooklyn,
NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145
Follow us on LinkedIn: https://www.linkedin.com/company/imarc-group/

#psychosismarkettreatment #therapies #mentalhealth #HealthcareInnovation #MarketGrowth #PharmaTrends